3D Evaluation of Maxillary Expansion Methods

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-12
SponsorBüşra Zeynep Yörük

About this trial

This controlled prospective clinical trial aims to evaluate the effectiveness of different maxillary expansion methods in children with maxillary transverse deficiency. A total of 60 participants will be included: 20 patients will receive Invisalign Palatal Expander (IPE), 20 will receive acrylic cap splint Rapid Maxillary Expansion (RME), and 20 will serve as an untreated control group. Three-dimensional (3D) intraoral and extraoral scans will be taken at the end of expansion, at 3 months, and at 6 months. Primary outcomes include maxillary arch width, first molar angulation, palatal surface area, and palatal volume. Secondary outcomes include soft tissue changes in the facial region. This study provides a direct comparison between a traditional and a modern digital expansion method, generating evidence for clinical decision-making in pediatric orthodontics.

Eligibility criteria

Qualifiers

Children aged 6-12 years

Good oral hygiene and adequate patient cooperation

No previous orthodontic expansion treatment

Disqualifiers

Systemic diseases affecting growth, bone metabolism, or craniofacial development

Craniofacial syndromes or congenital anomalies

Severe behavioral or cooperation problems

Previous orthodontic or orthopedic maxillary expansion

Trial design

Treatments tested in this trial

  • Invisalign Palatal Expander (IPE)
  • Acrylic Cap Splint Rapid Maxillary Expansion (RME) Appliance

Treatment groups

60 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Büşra Zeynep Yörük

Lead sponsor

Bezmialem Vakif University

Sponsor institution

Centerdent Orthodontics & Aesthetic Dentistry Clinic

Collaborator